HomeInsightsMarket Capitalization

Market Capitalization of Granules India Ltd

Market Capitalization of Granules India Ltd

stocks purchased

₹ 2.1 Cr

Volume Transacted

(Dec 12, 2024)

stocks purchased

35.9 K

Stocks Traded

(Dec 12, 2024)

Last Updated on: Dec 12, 2024

Image

Granules India Ltd

NSE: GRANULES

Market Cap

₹ 14280.36 crore

Last updated on: Dec 12, 2024

Key Highlights

  • The Market Cap of Granules India Ltd is ₹ 14280 crore as of 12 Dec 24 .
  • The Market Cap of Granules India Ltd changed from ₹ 2906 crore on March 2019 to ₹ 10420 crore on March 2024 . This represents a CAGR of 23.72% over 6 years.
  • The Latest Trading Price of Granules India Ltd is ₹ 589.2 as of 12 Dec 15:30 .
  • The Dividend Payouts of Granules India Ltd changed from ₹ 0.25 on Aug 05, 2021 to ₹ 1.5 on Jul 30, 2024 . This represents a CAGR of 34.80% over 6 years.

Historical Market Cap of Granules India Ltd

No data available

* All values are in crore

Company Fundamentals for Granules India Ltd

No data available

Image

Granules India Ltd

NSE: GRANULES

Share Price

₹ 589.2

4.20 (0.72%)

stock direction

Last updated on: Dec 12, 2024

Market Price of Granules India Ltd

1M

1Y

3Y

5Y

Monitoring Granules India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
12 Dec 2024589.2
11 Dec 2024585
10 Dec 2024583.15
09 Dec 2024579.9
06 Dec 2024576.05
05 Dec 2024567.2
04 Dec 2024542.5
03 Dec 2024534.45
02 Dec 2024594.65
29 Nov 2024586.85

SWOT Analysis Of Granules India Ltd

Strength

4

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Granules India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Granules India Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Granules India Ltd

No data available

No data available

Historical P/E Ratio of Granules India Ltd

No data available

* All values are in %

Historical Revenue of Granules India Ltd

No data available

* All values are in crore

Historical EBITDA of Granules India Ltd

No data available

* All values are in crore

Historical Net Profit of Granules India Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Granules India Ltd

No data available

* All values are in

About Granules India Ltd

  • Granules India Limited is a large-scale vertically integrated company founded in March 18th, 1991 manufacturing Active Pharmaceutical Ingredient (API), Pharmaceutical Formulation Intermediate (PFI) and Finished Dosage (FD).
  • With a strong presence across all three vertical, the company has created a leadership position in the off-patent drugs segment along with ensuring a strong presence in first line of defense' products such as Paracetamol, Ibuprofen, Metformin and Guaifenesin.
  • The company has a global presence across over 80 countries servicing over 300 customers.
  • Granules India is the preferred supplier for some of the world's leading pharma branded and generics companies.
  • The company has one of largest PFI and single site FD facilities in the world.

Granules India Ltd News Hub

News

Granules India Ltd gains for fifth session

Granules India Ltd is up for a fifth straight session in a row. The stock is quoting at Rs...

Read more

10 Dec 2024 13:00

News

Granules India Ltd leads losers in 'A' group

C.E. Info Systems Ltd, Zen Technologies Ltd, Deepak Nitrite Ltd and Avalon Technologies Lt...

Read more

03 Dec 2024 15:00

News

Granules India drops after USFDA's 'OAI' status to Gagillapur unit

The United States Food and Drug Administration (USFDA) has further classified the inspecti...

Read more

03 Dec 2024 15:25

News

Granules India Ltd gains for third straight session

Granules India Ltd gained for a third straight session today. The stock is quoting at Rs 5...

Read more

02 Dec 2024 13:05

News

Granules India receives SBTi validation and approval for its net-zero goals

Granules India has received validation and approval from the Science Based Targets initiat...

Read more

27 Nov 2024 16:11

News

Granules India Andhra Pradesh facility gets EIR from USFDA

This US drug regulator conducted an inspection from 8 April to 12 April 2024. Now, the ins...

Read more

08 Nov 2024 13:26

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Granules India Ltd Market Cap

What is the market cap of Granules India Ltd?

As of December 12, 2024, Granules India Ltd has a market capitalization of ₹14280.36, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Granules India Ltd's market capitalization?

Granules India Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Granules India Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Granules India Ltd's market capitalization change?

Granules India Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions